Advertisement
Screener

SILEXION THERAPEUTICS CORP (SLXN) Deferred Tax Assets, Other

2.8 / 5 stars · 68/120 Roast Me

SILEXION THERAPEUTICS CORP Deferred Tax Assets, Other

SILEXION THERAPEUTICS CORP (SLXN) had Deferred Tax Assets, Other of $55.00 thousand as of 2025-12-31, per its S-1/A filed 2026-08-10.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOther · last filed 2026-08-10

  • 2025-12-31: Deferred Tax Assets, Other $55.00K.
  • 2024-12-31: Deferred Tax Assets, Other $42.00K.
  • 2023-12-31: Deferred Tax Assets, Other $25.00K.
Period endDeferred Tax Assets, Other
2025-12-31$55.00K
S-1/A · filed 2026-08-10
2024-12-31$42.00K
S-1/A · filed 2026-08-10
2023-12-31$25.00K
8-K · filed 2025-08-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
CURIS INC (CRIS)United States$0.002B-0.05
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
VivoSim Labs, INC. (VIVS)United States$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70